Stock LXB LUXBRIGHT AB
Add to a list
To use this feature you must be a member
Log inSign up

Financials Luxbright AB

Equities

LXB

SE0015192075

Advanced Medical Equipment & Technology

Delayed Nasdaq Stockholm
Other stock markets
 14:55:46 01/07/2024 BST 		5-day change 1st Jan Change
0.975 SEK +9.55% Intraday chart for Luxbright AB +11.43% +134.38%
02-23 Luxbright AB Reports Earnings Results for the Full Year Ended December 31, 2023 CI
2023 Luxbright AB Reports Earnings Results for the Half Year Ended June 30, 2023 CI

Valuation

Fiscal Period: December 2022 2023
Capitalization 1 66.88 18.42
Enterprise Value (EV) 1 59.87 4.591
P/E ratio -2.77 x -1.12 x
Yield - -
Capitalization / Revenue 82.4 x 21.6 x
EV / Revenue 73.8 x 5.37 x
EV / EBITDA -2.92 x -0.19 x
EV / FCF - -
FCF Yield - -
Price to Book 2.4 x 1.14 x
Nbr of stocks (in thousands) 44,290 44,290
Reference price 2 1.510 0.4160
Announcement Date 21/05/24 21/05/24
1SEK in Million2SEK
Estimates

Income Statement Evolution (Annual data)

Fiscal Period: December 2018 2019 2022 2023
Net sales 1 1.4 2.178 0.8117 0.8547
EBITDA 1 -12.06 -10.52 -20.53 -24.35
EBIT 1 -12.08 -10.55 -21.15 -26.03
Operating Margin -862.71% -484.36% -2,606.04% -3,046.03%
Earnings before Tax (EBT) 1 -12.26 -10.65 -21.13 -25.38
Net income 1 -12.26 -10.65 -21.13 -25.38
Net margin -875.41% -489.19% -2,603.66% -2,968.9%
EPS - - -0.5450 -0.3728
Free Cash Flow - - - -
FCF margin - - - -
FCF Conversion (EBITDA) - - - -
FCF Conversion (Net income) - - - -
Dividend per Share - - - -
Announcement Date 29/02/20 29/02/20 21/05/24 21/05/24
1SEK in Million
Estimates

Balance Sheet Analysis

Fiscal Period: December 2018 2019 2022 2023
Net Debt 1 - - - -
Net Cash position 1 5.64 4.27 7.01 13.8
Leverage (Debt/EBITDA) - - - -
Free Cash Flow - - - -
ROE (net income / shareholders' equity) -2,568% -122% -87.2% -82.5%
ROA (Net income/ Total Assets) -61.4% -43.2% -47.9% -45.3%
Assets 1 19.98 24.65 44.11 56.05
Book Value Per Share - - 0.6300 0.3700
Cash Flow per Share - - 0.1700 0.1500
Capex - - - -
Capex / Sales - - - -
Announcement Date 29/02/20 29/02/20 21/05/24 21/05/24
1SEK in Million
Estimates

EPS & Dividend

Year-on-year evolution of the PER

Change in Enterprise Value/EBITDA

Sector Other Advanced Medical Equipment & Technology

1st Jan change Capi.
LUXBRIGHT AB Stock Luxbright AB
+134.38% 7.74M
THERMO FISHER SCIENTIFIC Stock Thermo Fisher Scientific
+4.96% 211B
DANAHER CORPORATION Stock Danaher Corporation
+7.95% 185B
INTUITIVE SURGICAL, INC. Stock Intuitive Surgical, Inc.
+32.20% 158B
SIEMENS HEALTHINEERS AG Stock Siemens Healthineers AG
+3.38% 64.32B
EDWARDS LIFESCIENCES CORPORATION Stock Edwards Lifesciences Corporation
+21.70% 55.66B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD. Stock Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
+0.11% 48.41B
AGILENT TECHNOLOGIES, INC. Stock Agilent Technologies, Inc.
-5.52% 37.82B
GE HEALTHCARE TECHNOLOGIES INC. Stock GE HealthCare Technologies Inc.
-0.05% 35.57B
RESMED, INC. Stock ResMed, Inc.
+11.15% 28.12B
Other Advanced Medical Equipment & Technology
  1. Stock Market
  2. Equities
  3. LXB Stock
  4. Financials Luxbright AB